Enanta Pharmaceuticals reported $450.44M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Amgen AMGN:US $ 59773M 2766M
Anika Therapeutics ANIK:US $ 363.13M 0.88M
Arrowhead Research ARWR:US $ 734.93M 21.87M
AstraZeneca AZN:LN 73641M 8715M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Biogen BIIB:US $ 24470.4M 615.7M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Clovis Oncology CLVS:US $ 572.23M 23.39M
Enanta Pharmaceuticals ENTA:US $ 450.44M 17.33M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Insmed INSM:US $ 1.23B 537.39M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Ligand Pharmaceuticals LGND:US $ 1256.28M 38.84M
Marinus Pharmaceuticals MRNS:US $ 124.99M 8.87M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NOVN:VX SF 124015M 2263M
Novavax NVAX:US $ 2749.59M 141.22M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
Vital Therapies VTL:US $ 136.06M 18.67M
YTE INCY:US $ 3904.62M 243.19M